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whole cell I-V relation (Table). IPC prior to ischernia eliminated these changes. Conclu- 
sion: These data, suggest that ischemia results in a significant change in the sarcolem- 
mal I-V relationship and that IPC prevents this potentially deleterious change. Studying 
the properties of surviving cells may provide insights into the cellular basis of myoprotec- " 
t/on. 
Quantification of the Be 2+ Sensitive Current-Voltage Relationship 
Control Ischemia IPC 
Number of animals/cells 5/16 4/14 5/9 
Peak Outward Current (Imax, pNpF) 0.9±0.1 2.1±0.3" 1.0±0.3 
V at Irna x (mV) -48¢1 -41±3# -44¢3 
V at 1/21max (mV) -33±1 -22¢3* -31 ±3 
Integral of Iou twith respect to dV (mVpA/pF) 34±5 98±14" 32±12 
Data: mean±sam; Imax=maximum current; V at Imax=voltage at maximum current; V at 
Y=lma x =voltage [positive to V(Imax) ] at Y2 of maximum current; Integral of lout with 
respect to dV=lntagral from 0 mV to reversal potential; # =p<0.05 vs Control; *=p<0.05 
vs Control and IPC 
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1169MP-126 Amlodipine Increases Coronary Blood Flow and 
Reduces the Severity of Myocardial lechemia in Canine 
Hearts: Roles of NO and Adenosine 
Hiroshi Asanuma. Masafumi Kitakaze, Koichi Node, Shoji Sanada, Hisakazu Ogita, Seiji 
Takashima, Masanod Asakura, Tetsuo Minamino, Michihiko Tada, Masatsugu Hod, 
Osaka University Graduate School of Medicine, Suita, Japan, National Cardiovascular 
Center, Suite, Japan. 
Background: Amlodipine is reported to increase NO production in the canine coronary 
artery via a bredykinin-dependent mechanisms, suggesting that amlodipine increases 
coronary blood flow via NO release in the ischemic heart. To test the hypothesis, we 
tested whether amlodipine increases coronary blood flow (CBF) and improves the sever- 
ity of myocardial ischemia. 
Methods: In 11 open chest beagle dogs, the left anterior descending coronary artery was 
perfused with blood from the carotid artery via the bypass tube, and then CBF and coro- 
nan/ perfusion pressure (CPP) were measured. After hemodynamic stabilization, CPP 
was reduced so that CBF decreased to 50 % of the baseline, using an occluder attached 
at the extracorporeal bypass tube and thereafter CPP was maintained constant at low 
levels. Ten rain after the onset of coronary hypoperfusion, we infused amlodipine into the 
coronary artery (1.5 p.g/kg/min) through the bypass tube with or without an inhibitor of NO 
synthase (L-NAME). 
Results: Amlodipine increased CBF (46.4 to 73.8 ml/100g/min, p<0.05), the differences 
in nitreta+nitrite concentration between coronary venous and artedal blood (VA (NO) D, 
11 to 30 nmol/ml, p<0.05), fractional shortening (FS, 0.4 to 11.3 %, p<0.05), and lactate 
extraction ratio (LER, -33.7 to -1.0 %, p<0.05). L-NAME (10 ~g/kg/min) blunted the amlo- 
d/pine-induced increases in CBF (49.2 to 47.8 ml/100g/min), VA (NO) D (10 to 9 nmol/ 
ml), FS (3.5 to 2.1%) and LER (-29.3 to -34.4 %). We found that cardiac adenosine lev- 
els (the differences of the plasma adenosine levels between coronary venous and arta- 
hal blood) are increased by the amlodipine administration (120 to 480 pmol/ml), and the 
antagonist of adenosine receptors partially blocked the amlodipine-induced coronary 
vasodilation. Since adenosine increases NO production, amlodipine-induced coronary 
vasodilation is attdbutable to the adenosine-NO linkages. 
Conclusion: We conclude that amlodipine increases coronary blood flow via enhanced 
production of either adenosine or NO, and improves contractile and metabolic dysfunc- 
tion of ischemic myocardium. 
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1169MP-127 Distinct Mechanisms of Mitochondrial ATP- Sensitive K 
Channel Opening by NIcorandil and Diazoxide: 
Dependence of PKC Activation 
Nozomu Harada, Toshiro Miura, Yuka Dairaku, Kazuko Iwarnoto, Ryosuke Kametani, 
Yasuhiro Iksda, Masunori Matsuzaki, Yamaguchi Universi~ Uhe, Japan. 
Background: Subcellular mechanism of cardioprotectien has been implicated activation 
of protein kinase C (PKC) and subsequent activation of mitochondrial ATP sensitive K 
(mitoKATP) channels. Nicorandil is known as a hybrid of nitric oxide donor and KATP 
channel opener, and diazoxide is a direct mitoKATP channel opener. We examined 
whether these two mitoKATP channel openers have distinct molecular mechanisms in 
terms of PKC isoform activation. Method and Result: We examined the effect of nic- 
orandil (NIC, 100 pM) and diazoxide (DZX, 100 ~M) on infarct size and PKC isoform 
trans)ocation to mitochondria in ischemia-reperfused rat heart. Administration of NIC and 
DZX before 30-min ischemia followed by 6-h repedusion reduced infarct size (28+2%, 
40+4%, respectively vs control 72±4%, P<O.05). When PKC inhibitor chelerythrine (5}~M) 
was administered pdor to NIC or DZX, the protective effect of NIC was attenuated 
(56±5%), but not in DZX(39~4%). On western blotting, the translocation of PKCA to mito- 
chonddal fraction was increased by NIC treatment by 29+~%, but not observed in DZX 
treated hearts. The translocation of other isoform ~. to mitochoodda was not significant. 
Conclusion: The anti-infarct effect of NIC was partly attributed to the translocation of 
PKCA to rnitochondda, which may subsequently activate mitoKATP channels synergisti- 
cally with its direct mitoKATP channel opening. This mechanism may be attributed to the 
nitric oxide donor effect of NIC, which is distinct from DZX. 
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1169MP-128 Dobutamine-lnduced Stress With Flow Restriction 
Causes Marked Lactate Production Despite No Change 
in Myocardial Oxygen Consumption or Fatty Acid 
Uptake 
Marearet P. Chandler, Tracy A. McEIfresh, Hazel Huang, William C. Stanley, Case 
Western Reserve Universi~ Cleveland, Ohio. 
Background: Stress-induced angina is due to a failure to increase coronary blood flow in 
response to an increase in demand for 02 delivery. We have shown that dobutamine 
(DOB) infusion causes a 2.5 fold increase in myocardial 02 consumption (MMO2), blood 
flow and free fatty acid (FFA) and lactate uptake in anaesthetized swine 
(CardiovasRes32:879,1996). We tested the hypothesis that DOB + flow restriction will 
result in no change in FFA uptake or MVO2, but will stimulate anaerobic glycolysis and 
result in a switch from lactate uptake to production. 
Methods: Measurements were made in the anterior wall of anesthetized open-chest 
swine heads (n=6). The left anterior descending (LAD) coronary artery flow was con- 
trolled via an extracorporeal perfusion circuit. Substrata uptake and oxidation was mea- 
sured with [U-14C] glucose and [9,10-3H] oleate. Stress-induced ischaemia was 
produced by i.v. DOB (15 IJg/kg/min) and 20% reduction in LAD flow for 20 m/n, and arte- 
rial and coronary venous blood were sampled. 
Results: DOB+ flow restriction resulted in significant increases in HR, peak LV dP/dt and 
glucose oxidation, but did not change MVO 2 or FFA uptake. In contrast, there was a dra- 
matic switch from lactate uptake to production. 
Conclusions: Ischemia induced by DOB+ flow restriction resulted in a massive stimula- 
tion of anaerobic glycolysis and lactate production despite a high residual MVO 2 and 
continued reliance on FFA as the main source of oxidative fuel. 
Control DOB+ Restriction 
Tissue Lactate (pmol/g) 3.9 + 1.1 11.0 ± 0.4 * 
Net La Production(~mol/min) -8.6 +~?..1 83.1 ± 21.4 * 
Ant. Wall MVO 2 (l~mol/min) 131 ± 16 113 ± 10 
FFA Tracer Uptake (p.mol/min) 8.4 ± 1.1 8.5 ± 1.5 
Glucose Oxidation(pmol/min) 2.5 ± 0.7 3.3 ± 0.6 * 
* P<0.05 
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1169MP-129 Rapid Expansion of Anatomical No-Reflow During 
Reperfusion in the Rabbit 
Thorstan Reffalmann, Robert A. KIoner, The Heart Institute, Good Samaritan Hospital, 
University of Southern California, Los Angeles, California. 
Background: There has been increased awareness of the no-reflow phenomenon fol- 
lowing reparfusion therapy for acute myocardial infarction. However, its time course and 
potential progression over time in relationship to infarction requires clarification. Meth- 
ods: 30 minutes of coronary occlusion (open-chest rabbits) were followed by either 2, 30, 
60, 120 or 480 rain of reperfusion (n=8, each). At the end of repedusion, the area of no- 
reflow was determined by injection of 1 ml/kg Thioflavin S, the risk area (RA) by blue dye 
after reocclusion and area of necrosis (AN) by tetrazolium-staining. At different time 
points, regional myocardial blood flow (RMBF) was measured by radioactive micro- 
spheres (M±SEM). Results: ANR rapidly expanded during the first two hours of reperfu- 
sion, increasing from 12% at 2 rain of repedusion to 30-34% of the RA at 2 - 8 hours of 
reperfusion. This corresponded to an ANR that accounted for 80~4% and 78±5% of the 
AN at 2 and 8 hours. ANR and AN strongly correlated with each other (r=0.84-0.95). 
RMBF in the RA declined within the first two hours of reperfusion, plateauing at a value of 
about 1 ml/g/min (26±5% of non-ischemic flow). ANR correlated positively with the dura- 
tion of reperfusion (p<0.008). RMBF correlated inversely (p<0.002) to the duration of red- 
effusion.Conclusions: The size of anatomical no-reflow largely depends on reperfusion 
injury, expanding rapidly and dramatically over the first two hours of reperfusion to 
encompass about 80% of the infarct with an associated fall in RMBF. 
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